SCHEMBL6168965

SCHEMBL6168965

CCOC(=O)c1ccc([N+](=O)[O-])c(NC(=O)C(Cc2ccc(-c3ccccc3)cc2)OC)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.48
CYP1A2 P05177 1/20 0.48
KMT2A Q03164 3/20 0.48
ABCB1 P08183 4/20 0.45
ALDH1A1 P00352 5/20 0.45
MAPT P10636 3/20 0.45
PTGER4 P35408 1/20 0.45
NPC1 O15118 2/20 0.45
PKM P14618 1/20 0.45
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
POLB P06746 2/20 0.44
LMNA P02545 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
ABCC1 P33527 1/20 0.44
MEN1 O00255 2/20 0.41
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172633 0.89 KMT2A (0.49) RAB9ACYP1A2KMT2AABCB1ALDH1A1
SCHEMBL6197847 0.89 LNPEP (0.52) RAB9AKMT2AALDH1A1MAPTPTGER4
SCHEMBL6169030 0.82 KMT2A (0.52) RAB9ACYP1A2KMT2AALDH1A1MAPT
SCHEMBL6172642 0.80 RAB9A (0.56) RAB9ACYP1A2KMT2AABCB1ALDH1A1
SCHEMBL6197001 0.79 KMT2A (0.48) RAB9AKMT2AALDH1A1MAPTPTGER4
SCHEMBL6170000 0.79 KMT2A (0.57) RAB9ACYP1A2KMT2AALDH1A1MAPT
SCHEMBL6168964 0.78 RAB9A (0.48) RAB9ACYP1A2KMT2AALDH1A1MAPT
SCHEMBL8129523 0.77 ALDH1A1 (0.58) RAB9AKMT2AALDH1A1MAPTPTGER4
SCHEMBL6170252 0.77 KMT2A (0.60) RAB9ACYP1A2KMT2AABCB1ALDH1A1
SCHEMBL6172669 0.77 KMT2A (0.52) RAB9AKMT2AALDH1A1MAPTPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed